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Abstract 
Background: Immature platelet fraction (IPF) estimation is a non-invasive and sensitive test 
that is available on recently introduced Sysmex XN-series of automated haematology analysers. It 
is a direct cellular indicator of thrombopoiesis. The aim of this study was to establish 
reference intervals for IPF, for both absolute (A-IPF) and percentage (%-IPF) measurements.  
Materials and Methods: A total of 2366 samples that met the inclusion criteria were assayed for 
full blood count on the Sysmex XN-10 and a non-parametric percentile method was used for 
calculating the reference intervals.  
Results: After the outliers were excluded, the reference interval for %-IPF and A-IPF on Sysmex 
XN-10 were 1.6–10.1% and 4.37–23.21 x 109/l in total individuals, respectively. There was a 
statistical significance noted between the sexes (P= 0.004) for %-IPF, therefore a sex-specific 
reference interval was established, which was 1.8–10.0% for the males and 1.5–10.1% for 
females. No significant difference in sex status for A-IPF and age status for both %-IPF and A-
IPF was observed. A very poor correlation was estimated between age versus %-IPF, ρ=0.0156, 
and age versus A-IPF, ρ=-0.0023, indicating that there is no overall biological relationship 
between age and these parameters. As expected, a strong correlation between %-IPF and A-IPF 
was noted which could be attributed to their inter-relatedness.  
Conclusion: This large-scale study showed comparable reference intervals with the previous 
studies for %-IPF and A-IPF in a UK population. It found the need to establish sex-specific 
reference intervals for %-IPF, but not for A-IPF, whereas reference intervals were found to be 
stable across the age range.  
Keywords: reference values, blood platelet, haematology, thrombocytopenia, blood cell count, 
haematologic tests, haematologic diseases, clinical laboratory techniques, clinical laboratory 
services, United Kingdom 
Introduction 
Ingram and Coopersmith first showed that the number of immature platelets increase following 
acute blood loss [1]. Using a new methylene blue dye, these immature platelets demonstrated 
coarse, punctate, condensations [reticulum; thus called reticulated platelets (RP)] and are 
considered analogous to reticulocytes. Two decades later, it was reported that flow cytometry could 
detect platelet nucleic acid in RP using a dye that was named ‘thiazole orange’ [2]. Subsequent 
reports thus focused on flow cytometric analysis of these RNA-rich RPs using RNA binding dyes 
to provide information on thrombopoietic activity [3] in a variety of conditions such as: 
thrombocytopenia [4-10], thrombocytosis [11,12], thrombo-embolic disorders [13,14], hereditary 
platelet diseases [15,16], following stem cell transplantation [17-20], hyperthyroidism [21], kidney 
disease [22-24], preeclampsia [25], and thrombocytopenic and healthy neonates [26,27]. 
Accordingly, RP became reliably expressed as the immature platelet fraction (IPF) which replaced 
labour-intensive manual procedures and time consuming general flow cytometry. These studies 
concluded that IPF is a useful, non-invasive, marker for megakaryopoietic activity [28].  
In current clinical practice, %-IPF is measured by different haematology analysers ranging from 
Sysmex XE-series to XN-series [29]. The Sysmex XE-2100 (Sysmex, Kobe, Japan) was introduced 
in 1999 [30]. Subsequently, this analyser underwent a number of upgrades, including an automated 
method for measuring %-IPF, using flow cytometry [31]. In 2007, the Sysmex XE-5000 was 
launched with additional parameters [32]. A more advanced XN Modular analyser was introduced 
in 2011 which was similar to the previous XE-series instruments measuring red cell parameters 
and impedance platelets in the same way. Four new channels were introduced including a 
fluorescent platelet (PLT-F) channel which provided a better sensitivity and specificity for 
measuring %-IPF compared to the previous versions of Sysmex haematology analysers [32]. IPF 
can be reported as both the percentage of immature platelets (%-IPF), which the analyser generates, 
as well as absolute-IPF (A-IPF), which is a calculated measurement using both the platelet count 
and %-IPF [33].  
 
Earlier reference intervals that were established using the XE-series may be invalid for the XN-
series of haematology analysers. More recent studies conducted in China [29] and Korea [34] have 
used the XN-series, but have reported different reference intervals which may be associated with 
racial and ethnic variation. The aim of the present study, which is the largest study to date, was to 
establish new reference intervals for A-IPF and %-IPF in a UK population, for the first time, using 
the Sysmex XN-10 automated haematology analyser.   
 
Materials and Methods 
Sample Requirement and Inclusion Criteria  
Samples of venous whole-blood collected in ethylenediaminetetraacetic acid K2 (EDTA K2) 
Vacutainer tubes and received from primary care providers in the Department of Haematology at 
Homerton University Hospital were analysed on Sysmex XN-10. To minimise variations due to 
sample aging, all tests were completed within 12 hours of collection. A total of 2366 samples with 
routinely reported FBC parameters within the reference range were assayed by selecting PLT-F 
mode on the Sysmex XN-10. All samples that met the following inclusion criteria were included 
in this study: (i) haemoglobin (Hb) 115–165 g/L [females] and 130–180 g/L [males]; (ii) red blood 
count (RBC) 3.80–5.80 x 1012/L [females] and 4.50–6.50 x 1012/L [males]; (iii) haematocrit (HCT) 
0.37–0.47 L/L [females] and 0.40–0.54 L/L [males]; (iv) mean cell volume (MCV) 80–98 fL; (v) 
mean cell haemoglobin (MCH) 27–32 pg;(vi) mean cell haemoglobin concentration (MCHC) 310–
350 g/L; (vii) red blood cell distribution width (RDW) 10–14%; (viii) platelet count (PLT) 150–
400 x 109/L; (ix) white blood count (WBC) 4.0–11.0 x 109/L; (x) neutrophil count (NEUT) 2.0–
7.5 x 109/L; (xi) lymphocyte count (LYMPH) 1.0–4.0 x 109/L; (xii) monocyte count (MONO) 0.2–
1.0 x 109/L; (xiii) eosinophil count (EO) 0.0–0.4 x 109/L; and (xiv) basophil count (BASO) 0.0–
0.1 x 109/L. Daily and weekly internal quality procedures were used for validating the quality of 
the results and imprecision was kept minimal with excellent intra-assay coefficients of variability 
(CV) of < 2% for 11 repeat analysis cycles (precision check).  The study received a favourable 
opinion from the National Research Ethics Service (NRES).  
Measurement of immature platelets 
EDTA K2 anticoagulated, whole-blood, samples were measured on the Sysmex XN-10 analyser 
(Sysmex, Kobe, Japan) which is a widely used, routine, fully-automated haematology analyser. 
Compared to its previous versions, this analyser uses different principles, channels, and reagents 
with improved sensitivity and specificity for %-IPF measurement [32]. In addition to impedance 
(PLT-I) and optic (PLT-O) methods for measuring platelet counts, the Sysmex XN-10 has a novel 
PLT-F-channel dedicated to measuring mature and immature platelets (Figure 1). This channel was 
introduced to improve the gating of platelets to achieve a more accurate platelet count (PLT-F), 
using the new fluorescent method, and %-IPF. The analyser uses an algorithm to determine which 
platelet count to use – impedance (PLT-I), optical (PLT-O) or the fluorescent method (PLT-F). 
The measurement of IPF requires platelet cellular membranes to be perforated by reagents, viz. a 
ﬂuorescent dye called oxadine, which stains the nucleic acids [32,35]. IPF enumeration is based on 
the principle of haemocytometry and is defined by an algorithm which gates for mature and 
immature platelets using side fluorescence (reflecting RNA content), side scatter (intracellular 
structure) and forward scatter (cell size) of light. An example of an IPF scattergram is shown in 
Figure 1. Immature platelets decrease in RNA content and size as they age, eventually becoming 
mature platelets [36]. It has been recently indicated that this RNA is used by platelets for protein 
synthesis [37]. 
Immature platelets – absolute number (A-IPF) and percentage (%-IPF) 
IPF is reported in two formats: as the percentage of platelets with above-threshold megakaryocyte-
derived RNA (%-IPF) - a value generated by XE- and XN-series automated haematology analysers 
- or the number of immature platelets per unit volume, known as the absolute-IPF (A-IPF). The A-
IPF can be calculated using the formula 
100
% CountPlateletIPF ⋅×−  [38]. Unlike %-IPF, the A-IPF is 
the exact number of immature platelets in the circulation [33].  
Statistical analysis 
Data was recorded in Excel files. Outliers, defined as values < Q1–1.5(IQR) or > Q3+1.5(IQR), 
[39] were checked and eliminated in addition to the data removed following application of the 
exclusion criteria. Statistical analysis was performed using Excel 2013 and RStudio (Version 
0.99.903) to analyse and graphically represent the data. Histograms were used to determine the 
distribution of the data and a normality test was performed using the Kolmogorov-Smirnov test 
[40]. Reference intervals were calculated according to the Clinical and Laboratory Standard 
Institute (CLSI) guideline EP28-A3c [41]; the non-parametric percentile method (2.5th and 97.5th 
percentiles) was used to calculate the reference intervals for %-IPF and A-IPF without making 
assumptions about the underlying distribution. This method is superior as no model-based data 
fitting is required [42]. Mann-Whitney Test was used to compare male and female counts only. 
Kruskal–Wallis one-way analysis of variance was used to compare the test parameters, %-IPF and 
A-IPF, with seven age subgroups mainly by decades including: 16-19 years; 20-29 years; 30-39 
years; 40-49 years; 50-59 years; 60-69 years; and 70-91 years.  Inter-correlations between age, %-
IPF and A-IPF were computed through the Spearman’s correlation which was used to assess the 
pairwise relationship between the variables. P values ≤ 0.05 were considered statistically 
significant. All data is expressed as 2.5th and 97.5th percentiles (central 95% percentiles) unless 
stated otherwise. 
Results 
A total of 2366 blood samples were collected from individuals with ages range from 16 to 91 years 
(765 males and 1527 females). 74 outliers were removed and the remaining 2292 samples were 
included in the data analysis. The distribution of both %-IPF and A-IPF (including the subgroups, 
data not shown) was non-Gaussian (non-parametric data with P < 0.05), showing left skewed 
histograms (Figure 2A and 2B) using visual examination. Unfortunately, it was not possible to 
repeat outlying %-IPF and A-IPF results due to the temporal requirements of the study design.  
This non-Gaussian distribution was confirmed by the Kolmogorov-Smirnov Z-test [40], which was 
used to test all variables for normality. A non-parametric distribution was shown in all subgroups, 
thus the Kruskal-Wallis rank sum test, Mann-Whitney U test, and Spearman's rank-order 
correlation were used to analyse the data.  
 
The reference interval data for %-IPF and A-IPF for total individuals and sex-divided subgroups 
are presented in Table 1. The reference interval for %-IPF was 1.6–10.1% (median %-IPF, 4.4%; 
median age, 41 years) in total individuals: 1.8–10.0% in males and 1.5–10.1% in females. The 
reference interval for A-IPF was 4.37–23.21 x 109/l (median A-IPF, 10.88 x 109/l; median age, 41 
years) in total individuals: 4.66–22.19 x 109/l in males and 4.36–23.49 x 109/l in females.  
 There was no statistical difference in the reference intervals between males and females for A-IPF 
(P= 0.373). Likewise, the Kruskal-Wallis rank sum test showed that there was no overall statistical 
significance amongst the seven age subgroups for both %-IPF (P=0.1186) and A-IPF (P= 0.3823), 
respectively. Furthermore, a statistical exploration of the correlation between age versus %-IPF – 
Spearman ρ=0.0156 (P= 0.454), and age versus A-IPF – Spearman ρ=-0.0023 (P= 0.9115), showed 
a statistically insignificant and substantially uncorrelated relationship (Figure 4). However, as 
shown in Figures 3 and 4, respectively, the two positive results this study yielded are a statistical 
difference in the reference intervals between males and females for %-IPF (P= 0.004) and the 
relationship between %-IPF and A-IPF which was statistically significant and highly correlated, 
Spearman ρ=0.909 (P < 0.001).  
 
Discussion 
After decades of technical challenges in enumerating immature platelets, a real-time IPF diagnostic 
tool is available on several automated Sysmex haematology analytical platforms. The clinical 
utility of this tool is reported in several conditions [4-27]. Of these, the role of immature platelets 
to indicate the mechanism of thrombocytopenia is well recognised [4-10] due to its ability to 
differentiate central and peripheral thrombocytopenias [31]. In 2012, an expert group published 
recommendations for the management of thrombocytopenia and strongly agreed that decisions to 
treat thrombocytopenia should consider, amongst other factors, mechanisms of thrombocytopenia 
[43]. To this end, IPF has the potential to offer insight into the underlying mechanisms of 
thrombocytopenia, although there is no fundamental UK-based reference interval data currently 
available for IPF on the Sysmex XN-series analysers for the purpose of future research and 
potential clinical use.  
 Historically, IPF reference intervals were determined using Sysmex predecessors (Sysmex XE-
2100 or XE-5000) or by using the XN-series analysers comprising individuals from a different 
population group [29,34]. Since the Sysmex XN-series utilises different principles for IPF 
measurement from its previous version [44], it is important to investigate whether the reference 
intervals established on the previous version are valid using the XN-series analysers. A slight 
difference was observed between reference intervals across a number of studies (Table 2) using a 
range of Sysmex haematology platforms. The reference intervals obtained on the Sysmex XN-
series were generally higher and demonstrated a wider distribution for both %-IPF and A-IPF 
compared to the measurement attained on the previous instruments (XE-series analysers) 
[29,31,34,45-54].  
 
In this study, we measured IPF in a large number of samples (total n=2366, aged ≥ 16 years old) 
with FBC parameters reported within population specific reference ranges. This is the largest study 
conducted to date for determining the reference intervals for %-IPF and A-IPF (Table 2). The 
reference interval for %-IPF and A-IPF was 1.6–10.1% and 4.37–23.21 x 109/l respectively, when 
specimens from both sexes were combined. However, a statistically significant difference between 
sexes was apparent and therefore this study established separate reference intervals for sex-specific 
subgroups for %-IPF – viz. 1.8–10.0% for males and 1.5–10.1% for females.  
 
Correlation analysis was also performed in this study; a biological relationship between age and 
%-IPF or A-IPF is highly unlikely in view of i) the extremely low coefficients of correlation 
(Spearman ρ= 0.0156 and ρ= 0.0023), ii) a rather low statistical significance (P = 0.454 and 
0.9115), and iii) the large number of data analysed (n=2292). In contrast, a positive association 
between %-IPF and A-IPF was conﬁrmed in a highly significant manner, as Figure 4 demonstrates, 
with a Spearman ρ= 0.909 (P < 0.001). This was expected as %-IPF values are used to calculate 
A-IPF, and therefore, a mathematical inter-relatedness exists between the two parameters.  
 
Overall, the reference intervals achieved in this study compared well with previous studies, 
especially for the same series of Sysmex instruments[29,34]. There was a larger variation reported 
for %-IPF and A-IPF between our study and those conducted on earlier instruments, most of which 
were considerably narrower than our reference intervals. This variation between studies may 
represent differences in: the platforms used, populations studied, and methodologies adopted for 
determining reference intervals and excluding outliers. Therefore, a standardised application of this 
parameter in a clinical setting has been somewhat difficult [55] and a need for instrument-specific 
reference intervals is vindicated.  
 
The present study has three limitations. Firstly, the XN-10 used an automated switching algorithm 
to report the most accurate platelet count (PLT-I, PLT-O, or PLT-F). This was then used to 
calculate the A-IPF instead of setting fluorescent platelets (PLT-F) as a fixed method for this 
purpose. This may have slightly increased the A-IPF values because the PLT-I and PLT-O are 
known to generate higher platelet counts compared to the PLT-F [56]. Secondly, this study did not 
stratify reference intervals according to ethnicity and clinical situations. This may restrict the 
application of these reference intervals in different ethnic populations and may impact on its value 
in the clinical setting. Thirdly, the influence of biological variation that is essential for analytical 
specifications and estimating reference change values was not verified in this study. This may limit 
the clinical interpretation of %-IPF and A-IPF [57] and therefore further studies are warranted to 
investigate the effects of biological variations.  
Conclusion 
We have generated reference intervals for both A-IPF and %-IPF in a UK population and found 
that for %-IPF there are sex-specific reference intervals, 1.8–10.0% for males and 1.5–10.1% for 
females.  Reference intervals for A-IPF are independent of sex and likewise reference intervals for 
both %-IPF and A-IPF are independent of age. There was a strong correlation between %-IPF and 
A-IPF which was expected due to the inter-relatedness of these parameters.  
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Table 1 Reference intervals for %-IPF and A-IPF on Sysmex XN-10 in samples from apparently 
healthy individuals. 
 n Total Males Females 
 
T 
 
M 
 
F 
 
 
RI 
 
RI 
 
Median 
 
Age 
Range 
 
RI 
 
Median 
 
Age 
Range 
%-IPF, % 2292 765 1527a 1.6-10.1c 1.8-10.0 4.6 16-91e 1.5-10.1 4.3 16-90f 
A-IPF, x 109/l 2292 765 1527b 4.37-23.21d 4.66-22.19 10.71 16-91e 4.36-23.49 10.97 16-90f 
 
A-IPF, absolute immature platelet fraction; %-IPF, percentage immature platelet fraction; T, total; 
M, males; F, females; n, sample size; and RI, reference interval. aP =  0.004 vs. males (Mann-
Whitney U-test), decision = rejectnull hypothesis; bP =  0.373 vs. males (Mann-Whitney U-test), 
decision = accept null hypothesis; cMedian, 4.4%; dMedian, 10.88 x 109/l ; eMedian, 42 years; and 
fMedian, 40 years. The data are expressed as 2.5th and 97.5th percentiles except for age range 
which is expressed as a whole range. 
Table 2 Comparison of reference intervals for A-IPF and %-IPF using Sysmex analytical platforms 
from 2004 to date. 
Instrument Population N sex %-IPF A-IPF 
(x109/l) 
Author Year of 
publication 
Sysmex XE-2100 UK 50 Male/Female 1.1-6.1 - Briggs[31] 2004 
Sysmex XE-5000 German 309 Male/Female 0.8-6.3 2.3-12.7 Pekelharing[53] 2010 
Sysmex XE-2100 South African 60 Male/Female 0.7-5.5 - Mogongoa [54] 2012 
Sysmex XE-5000 Brazil 132 Male/Female 0.8-5.6 - Morkis [45] 2016 
Sysmex XE-2100 Japan 82 Male/Female 0.5-5.7 1.4-10.4 Takami [48] 2007 
Sysmex XE-2100 South Korea 2152 Male/Female 0.5-3.3 1.25-7.02 Ko [49] 2013 
Sysmex XE-2100 USA 28 Not stated 0.8-10.1 2.1-19.6 Berny-Lang [46] 2015 
Sysmex XE-2100 India 945 Male/Female 0.3-8.7 - Sachdev [50] 2014 
Sysmex XE-2100 Italy 229 Male/Female 1.9-4.1 4.2-8.2 Cesari [51] 2013 
Sysmex XE-2100 India 100 Not stated 0.7-4.3 - Dadu [52] 2014 
Sysmex XE-5000 Denmark 1674 Male/Female 1.3-9.0 - Joergensen [47] 2016 
Sysmex XN9000 China 2179 Male/Female 0.4-10.8 0.8-23.0 Yang [29] 2017 
Sysmex XN and 
Sysmex XE-2100 
Korea 2104 Male/Female XN: 1.0-7.3 
XE: 0.5-3.3 
XN: 2.49-15.64 
XE: 1.25-7.02 
Ko [34] 2015 
Sysmex XN9000 UK 2366 Male/Female Total: 1.6-10.1 
Males: 1.8-10.0 
Females: 1.5-10.1 
Total: 4.37-23.21 Current study 2017 
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Figure Legends: 
Figure 1. Example of IPF scattergram of PLT-F channel on Sysmex XN-10 showing fluorescence 
intensity (RNA content) and forward scatter (size of the platelets) 
Figure 2. A. Frequency distribution of %-IPF (n=2366). B. Frequency distribution of A-IPF 
(n=2366).  
Figure 3. Boxplot of %-IPF data for sex subgroups (n=2292).  
Figure 4. Scatter plot matrix illustrating all possible pairwise relationships between variables (age, 
%-IPF and A-IPF). Age, years; %-IPF, %; A-IPF, x 109/l. Spearman's rank correlation rho between 
age and %-IPF, ρ= 0.0157 (P= 0.454); Spearman's rank correlation rho between age and A-IPF, ρ= 
-0.0023 (P= 0.9115); and Spearman's rank correlation rho between %-IPF and A-IPF, ρ= 0.909 (P 
< 0.001).  
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